At­las, No­vo-backed biotech reels in ex-Nim­bus CEO Don Nichol­son as ex­ec chair­man, hooks $50M to con­quer ane­mia

Bri­an Mac­Don­ald’s orig­i­nal for­ay in­to treat­ing iron dys­reg­u­la­tion by in­ject­ing hep­cidin, a small pep­tide hor­mone key for iron home­osta­sis, didn’t quite get off the ground …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER